LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
6.48
+0.02 (0.31%)
At close: Dec 5, 2025, 4:00 PM EST
6.60
+0.12 (1.85%)
After-hours: Dec 5, 2025, 7:53 PM EST
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for LifeStance Health Group stock have an average target of 9.00, with a low estimate of 8.00 and a high estimate of 10. The average target predicts an increase of 38.89% from the current stock price of 6.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LifeStance Health Group stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Initiates $8 | Buy | Initiates | $8 | +23.46% | Nov 13, 2025 |
| UBS | UBS | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +54.32% | Nov 7, 2025 |
| BTIG | BTIG | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +38.89% | Nov 6, 2025 |
| UBS | UBS | Strong Buy Maintains $8.5 → $9 | Strong Buy | Maintains | $8.5 → $9 | +38.89% | Aug 8, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $8.5 | Hold → Strong Buy | Upgrades | $8.5 | +31.17% | May 27, 2025 |
Financial Forecast
Revenue This Year
1.45B
from 1.25B
Increased by 15.75%
Revenue Next Year
1.66B
from 1.45B
Increased by 14.36%
EPS This Year
-0.02
from -0.15
EPS Next Year
0.04
from -0.02
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.5B | 1.7B | ||
| Avg | 1.4B | 1.7B | ||
| Low | 1.4B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 19.7% | 18.9% | ||
| Avg | 15.8% | 14.4% | ||
| Low | 11.0% | 8.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 0.07 | |
| Avg | -0.02 | 0.04 | |
| Low | -0.05 | -0.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.